Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

11.0K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
11.0K
The Retina01:32

The Retina

78.5K
The retina is a layer of nervous tissue at the back of the eye that transduces light into neural signals. This process, called phototransduction, is carried out by rod and cone photoreceptor cells in the back of the retina.
78.5K
Complement System01:27

Complement System

12.7K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
12.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repurposing Purine Analog Antivirals to Modulate Serum Uric Acid: Evidence From Real-World Data.

Clinical and translational science·2026
Same author

Acute cardiovascular events after discontinuation of xanthine oxidase inhibitors: a cohort study.

Clinical rheumatology·2025
Same author

Oral lamivudine in diabetic macular edema: A randomized, double-blind, placebo-controlled clinical trial.

Med (New York, N.Y.)·2025
Same author

Association of nucleoside reverse transcriptase inhibitor use with reduced risk of Alzheimer's disease risk.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

NLRP3 Activation With Bisphosphonate Use and the Risk of Incident Age-Related Macular Degeneration.

Investigative ophthalmology & visual science·2025
Same author

Deciphering age-related transcriptomic changes in the mouse retinal pigment epithelium.

Aging·2025

Related Experiment Video

Updated: Mar 31, 2026

Efficient Dissection and Culture of Primary Mouse Retinal Pigment Epithelial Cells
08:33

Efficient Dissection and Culture of Primary Mouse Retinal Pigment Epithelial Cells

Published on: February 10, 2021

7.4K

Complement Activation and Inhibition in Retinal Diseases.

Mark E Kleinman, Jayakrishna Ambati

    Developments in Ophthalmology
    |October 27, 2015
    PubMed
    Summary
    This summary is machine-generated.

    Immune system activation drives age-related macular degeneration (AMD) pathogenesis. Complement pathways are key targets for new AMD therapies, with ongoing trials evaluating their effectiveness.

    More Related Videos

    An Acute Retinal Model for Evaluating Blood Retinal Barrier Breach and Potential Drugs for Treatment
    09:33

    An Acute Retinal Model for Evaluating Blood Retinal Barrier Breach and Potential Drugs for Treatment

    Published on: September 13, 2016

    7.6K
    Digestion of Whole Mouse Eyes for Multi-Parameter Flow Cytometric Analysis of Mononuclear Phagocytes
    09:58

    Digestion of Whole Mouse Eyes for Multi-Parameter Flow Cytometric Analysis of Mononuclear Phagocytes

    Published on: June 17, 2020

    5.6K

    Related Experiment Videos

    Last Updated: Mar 31, 2026

    Efficient Dissection and Culture of Primary Mouse Retinal Pigment Epithelial Cells
    08:33

    Efficient Dissection and Culture of Primary Mouse Retinal Pigment Epithelial Cells

    Published on: February 10, 2021

    7.4K
    An Acute Retinal Model for Evaluating Blood Retinal Barrier Breach and Potential Drugs for Treatment
    09:33

    An Acute Retinal Model for Evaluating Blood Retinal Barrier Breach and Potential Drugs for Treatment

    Published on: September 13, 2016

    7.6K
    Digestion of Whole Mouse Eyes for Multi-Parameter Flow Cytometric Analysis of Mononuclear Phagocytes
    09:58

    Digestion of Whole Mouse Eyes for Multi-Parameter Flow Cytometric Analysis of Mononuclear Phagocytes

    Published on: June 17, 2020

    5.6K

    Area of Science:

    • Ophthalmology
    • Immunology
    • Pathogenesis of Age-Related Macular Degeneration (AMD)

    Background:

    • Decades of research highlight immune-mediated inflammation's role in AMD.
    • The exact contribution of immune responses versus other factors like senescence and oxidative stress in AMD initiation is debated.
    • Growing evidence implicates immune system activation as a primary driver of AMD.

    Purpose of the Study:

    • To review the current understanding of immune system activation in AMD pathogenesis.
    • To identify key immune-related factors, including complement components, as potential therapeutic targets.
    • To discuss the implications of complement activation and inhibition in AMD progression and treatment.

    Main Methods:

    • Review of existing scientific literature and research findings on AMD pathogenesis.
    • Analysis of data implicating immune system activation and specific molecular pathways.
    • Consideration of ongoing clinical trials for complement-targeted therapies.

    Main Results:

    • Abundant data confirm immune system activation as a significant impetus in AMD pathogenesis.
    • Identification of multiple inciting factors, notably complement-activating components.
    • Emerging therapeutic targets within the immune and complement pathways.

    Conclusions:

    • Immune system activation is a critical factor in the development of age-related macular degeneration.
    • The complement system presents a promising target for novel AMD therapeutic interventions.
    • Clinical trials are crucial for determining the role of complement pathways in AMD and evaluating new treatments.